Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics
75% of registered voters surveyed call diagnostic testing "very important" to their care, and a bipartisan majority wants Congress to pass the RESULTS Act before additional Medicare cuts are scheduled to take effect January 2027 SECAUCUS, N.J., Sept. 16, 2026 /PRNewswire/ -- A new...
Covered in this story
What has happened since
- Quest Diagnostics is down 4.7% since this was published, 34 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Quest Diagnostics
- Truist Securities: $228 → $250 by Jul 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $DGX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Quest Diagnostics →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.